Stage I Testicular Nonseminomatous Germ Cell Tumor
Oncology·MeSH: Sex Cord-Gonadal Stromal Tumors
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Stage I Testicular Nonseminomatous Germ Cell Tumor?
There are 1 clinical trial targeting Stage I Testicular Nonseminomatous Germ Cell Tumor tracked by BioSniper.
What is the prevalence of Stage I Testicular Nonseminomatous Germ Cell Tumor?
The estimated prevalence of Stage I Testicular Nonseminomatous Germ Cell Tumor is approximately 5.0 per 100,000 population.
Deep-dive into Stage I Testicular Nonseminomatous Germ Cell Tumor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis